Amarantus Bioscience Holdings Inc (AMBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2012 | 03-2012 | 12-2011 | 09-2011 | 06-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,313 | -1,317 | -4,440 | -2,302 | -1,630 |
| Depreciation Amortization | 6 | 3 | 15 | 11 | 11 |
| Accounts payable and accrued liabilities | 720 | 251 | 1,059 | 709 | 513 |
| Other Working Capital | 686 | 288 | 754 | 856 | 418 |
| Other Operating Activity | 634 | 601 | -203 | -10 | 139 |
| Operating Cash Flow | $-267 | $-174 | $-2,816 | $-736 | $-549 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | -5 | -19 | -24 |
| Investing Cash Flow | $N/A | $N/A | $-5 | $-19 | $-24 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 273 | 173 | 805 | 590 | 528 |
| Common Stock Issued | N/A | N/A | 1,995 | 144 | N/A |
| Other Financing Activity | 0 | 0 | -26 | -26 | 0 |
| Financing Cash Flow | $273 | $173 | $2,774 | $708 | $528 |
| Beginning Cash Position | 1 | 1 | 48 | 48 | 48 |
| End Cash Position | 7 | 0 | 1 | N/A | 2 |
| Net Cash Flow | $6 | $-1 | $-47 | $-48 | $-45 |
| Free Cash Flow | |||||
| Operating Cash Flow | -267 | -174 | -2,816 | -736 | -549 |
| Capital Expenditure | N/A | N/A | -5 | -19 | -24 |
| Free Cash Flow | -267 | -174 | -2,820 | -755 | -573 |